Surgery type trial for stomach cancer after chemo
Part of Cancer, Digestive system clinical trials.
This trial studies which surgical approach (removing lymph nodes in a more limited vs more extensive way) works best for gastric cancer after you’ve already started chemotherapy before surgery. It’s aimed at improving cancer control while keeping the operation as safe as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach cancer proven by biopsy (adenocarcinoma).
- Your cancer has no distant spread and is still expected to be operable based on scans and/or surgery planning.
- You finished at least one cycle of chemotherapy given before surgery.
- Your overall health is good enough for surgery (ECOG 0–1 means you’re fully active or limited but up and about).
- You can understand the study and agree to take part (signed informed consent).
- You don’t have certain other problems or situations (like another active cancer or blockage that prevents curative surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive surgery for stomach cancer that has spread to lymph nodes near the main blood vessels (para-aortic area). The surgery is done after a combination of chemotherapy and immunotherapy to shrink the tumor. It aims to see if this approach is safe and effective.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
This trial compares two approaches for stomach cancer that has spread a bit but can still be removed with surgery. One group has surgery first, the other gets chemotherapy before surgery. The goal is to see which sequence leads to better long-term outcomes.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
This trial studies whether a minimally invasive (laparoscopic) removal of the entire stomach, along with lymph node removal, can be done safely and effectively for certain stomach cancers. It may be an option if your cancer is in the stomach, has limited spread to nearby lymph nodes, and can be fully removed.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.